062239641	062239641	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
00415001	00415001	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3527154	3527154	CD	B-NP	O
|	|	CC	I-NP	O
9/10/2006	9/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Pumlmonary	Pumlmonary	NNP	I-NP	O
Embolism	Embolism	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/23/2006	4/23/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/17/2006	3/17/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BEDENFIELD	BEDENFIELD	NN	B-NP	O
,	,	,	O	O
ANIBAL	ANIBAL	NN	B-NP	O
641-89-55-0	641-89-55-0	CD	I-NP	O
No	No	NNP	I-NP	O
Heim	Heim	NNP	I-NP	O
Tlandlo	Tlandlo	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/12/06	2/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BACKBONE	BACKBONE	NN	B-NP	O
,	,	,	O	O
NUMBERS	NUMBERS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
SANDLING	SANDLING	NNP	B-NP	O
,	,	,	O	O
JAKE	JAKE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895481426	895481426	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
BOLAR	BOLAR	NNP	B-NP	O
,	,	,	O	O
CLEMENT	CLEMENT	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
620071238	620071238	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
AWARE	AWARE	NNP	B-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
IBUPROFEN	IBUPROFEN	NNP	I-NP	O
400-800	400-800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-DNA
ASACOL	ASACOL	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
MESALAMINE	MESALAMINE	NN	I-NP	I-DNA
TABLET	TABLET	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
800	800	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
TOPROL	TOPROL	NNP	I-NP	I-DNA
XL	XL	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
METOPROLOL	METOPROLOL	NNP	I-NP	I-DNA
SUCCINATE	SUCCINATE	NNP	I-NP	I-DNA
EXTENDED	EXTENDED	NNP	I-NP	I-DNA
RELEASE	RELEASE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
150	150	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
BID	BID	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5	5	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
HOVE	HOVE	NNP	B-NP	O
,	,	,	O	O
ROLANDO	ROLANDO	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895481426	895481426	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
GANLEY	GANLEY	NNP	B-NP	O
,	,	,	O	O
JOSHUA	JOSHUA	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
AWARE	AWARE	NN	B-NP	O
TRAZODONE	TRAZODONE	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8	8	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
BRIXEY	BRIXEY	NNP	B-NP	O
,	,	,	O	O
CARROL	CARROL	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Schlesinger	Schlesinger	NNP	I-NP	O
11/22	11/22	CD	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/4/06	2/4/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VNS	VNS	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pumlmonary	Pumlmonary	NNP	I-NP	O
Embolism	Embolism	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dysliipds	dysliipd	VBZ	B-VP	O
former	former	JJ	B-NP	O
smoker	smoker	NN	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
past	past	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
ulcerative	ulcerative	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
ulcerative	ulcerative	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
Elbert	Elbert	NNP	B-NP	O
Kinnier	Kinnier	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66	66	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
PMHx	PMHx	NN	B-NP	O
sig	sig	NN	I-NP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2	2	CD	B-NP	O
vessel	vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
10/19	10/19	CD	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
UC	UC	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
cc	cc	NN	B-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
s/p	s/p	NN	B-NP	O
CABG	CABG	NN	I-NP	O
on	on	IN	B-PP	O
6	6	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
That	That	NNP	I-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
trying	try	VBG	B-VP	O
to	to	TO	I-VP	O
sleep	sleep	VB	I-VP	O
.	.	.	O	O

SOB	SOB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
lying	lie	VBG	B-VP	O
down	down	RP	B-PRT	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
.	.	.	O	O

Sunday	Sunday	NNP	B-NP	O
3/10	3/10	CD	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
VNS	VNS	NN	B-NP	B-protein
who	who	WP	B-NP	O
suggested	suggest	VBD	B-VP	O
he	he	PRP	B-NP	O
come	come	VB	B-VP	O
into	into	IN	B-PP	O
ED	ED	NN	B-NP	O
for	for	IN	B-PP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
nml	nml	NN	B-NP	O
CXR	CXR	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
dropped	drop	VBD	B-VP	O
02	02	CD	B-NP	O
sat	sit	VBD	B-VP	O
while	while	IN	B-SBAR	O
sleeping	sleep	VBG	B-VP	O
to	to	TO	B-PP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Was	Wa	NNS	B-NP	B-protein
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
with	with	IN	B-PP	O
ltd	ltd	NN	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

6/2	6/2	CD	B-NP	O
CTA	CTA	NN	I-NP	O
showed	show	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
small	small	JJ	I-NP	O
embolic	embolic	JJ	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
-LRB-	-LRB-	HYPH	B-ADVP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
2.1	2.1	CD	B-NP	O
3/10	3/10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
120mg	120mg	NN	B-NP	O
lovenox	lovenox	NN	I-NP	O
at	at	IN	B-PP	O
5PM	5PM	NN	B-NP	B-DNA
6/2	6/2	CD	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
pt	pt	NN	I-NP	O
states	state	NNS	I-NP	O
SOB	SOB	NN	I-NP	B-protein
improved	improve	VBD	B-VP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
chest	chest	VBP	B-VP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
calf	calf	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
n/v/d	n/v/d	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
or	or	CC	I-NP	O
family	family	NN	I-NP	O
h/o	h/o	NN	I-NP	O
clots	clot	NNS	I-NP	O
.	.	.	O	O

PMHx	PMHx	NN	B-NP	O
:	:	:	O	O
CABG	CABG	NN	B-NP	O
7/29/2006	7/29/2006	CD	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
saphenous	saphenous	JJ	B-ADJP	O
to	to	TO	B-PP	O
first	first	JJ	B-NP	O
diagonal	diagonal	JJ	I-NP	O
EF	EF	NN	I-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
9/30	9/30	CD	B-NP	O
Afib	Afib	NN	I-NP	O
HTN	HTN	NN	I-NP	O
Hyperlipdemia	Hyperlipdemia	NN	I-NP	O
GERD	GERD	NN	I-NP	O
Ulcerative	Ulcerative	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
Obesity	Obesity	NN	I-NP	O
Osteoarthritis	Osteoarthritis	NN	I-NP	O
of	of	IN	B-PP	O
knees	knee	NNS	B-NP	O
Medcations	Medcation	NNS	I-NP	O
:	:	:	O	O
Asa	Asa	NNP	B-NP	O
81	81	CD	I-NP	O
Lipitor	Lipitor	NNP	I-NP	O
40mg	40mg	CD	I-NP	O
qday	qday	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
40mg	40mg	NN	I-NP	O
qday	qday	NN	I-NP	O
KCL	KCL	NN	I-NP	O
20meq	20meq	NN	I-NP	O
day	day	NN	I-NP	O
Asacol	Asacol	NNP	I-NP	O
800mg	800mg	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Toprol	Toprol	NNP	I-NP	O
150mg	150mg	NN	I-NP	O
BID	BID	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
8mg	8mg	NN	I-NP	O
qday	qday	NN	I-NP	O
Oxycodone	Oxycodone	NN	I-NP	O
5-10mg	5-10mg	JJ	I-NP	O
q6	q6	NN	I-NP	O
prn	prn	NN	I-NP	O
Allergies	Allergy	NNS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NNP	B-NP	O
Social	Social	NNP	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ETOH	ETOH	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

FHx	FHx	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
clots	clot	NNS	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
.7	.7	CD	B-NP	O
BP	BP	NN	I-NP	O
118/70	118/70	CD	B-NP	O
HR	HR	NN	I-NP	O
79	79	CD	B-NP	O
02	02	CD	I-NP	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
3L	3L	NN	I-NP	O
Weight	Weight	NN	I-NP	O
155	155	CD	I-NP	O
kg	kg	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
friendly	friendly	JJ	B-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	B-protein
,	,	,	O	O
A	A	DT	B-NP	O
&	&	CC	I-NP	O
0x3	0x3	CD	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERRLA	PERRLA	NN	B-NP	O
bil	bil	NN	I-NP	O
,	,	,	O	O
anicteric	anicteric	NN	B-NP	O
,	,	,	O	O
noninjected	noninjected	JJ	B-ADJP	O
.	.	.	O	O

MMM	MMM	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
supple	supple	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
flat	flat	NN	I-NP	O
,	,	,	O	O
ireggulyar	ireggulyar	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
nml	nml	NN	B-NP	B-protein
s1	s1	NN	I-NP	I-protein
,	,	,	O	O
s2	s2	NN	B-NP	O
Lungs	Lung	NNS	I-NP	O
:	:	:	O	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
lobes	lobe	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
Ab	Ab	VBP	B-VP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	I-NP	O
ND	ND	NN	I-NP	O
,	,	,	I-NP	O
noromactive	noromactive	JJ	I-NP	O
BS	BS	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cords	cord	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
Derm	Derm	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
rashes	rashe	VBZ	B-VP	O
Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
CN	CN	NN	B-NP	O
II-XII	II-XII	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
sensory	sensory	JJ	B-NP	O
and	and	CC	I-NP	O
motor	motor	NN	I-NP	O
grossly	grossly	RB	B-NP	O
intact	intact	JJ	I-NP	O
Labs	Lab	NNS	I-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
1.8	1.8	CD	B-NP	O
ECG	ECG	NN	I-NP	O
:	:	:	O	O
premature	premature	JJ	B-NP	B-protein
atrial	atrial	JJ	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
,	,	,	O	O
rate	rate	NN	B-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
CTA	CTA	NN	B-NP	O
9/25	9/25	CD	I-NP	O
Mult	Mult	NN	I-NP	O
bil	bil	NN	I-NP	O
pulm	pulm	NN	I-NP	O
emboli	embolus	NNS	I-NP	O
,	,	,	O	O
segmental	segmental	JJ	B-NP	O
and	and	CC	I-NP	O
subsegmental	subsegmental	JJ	I-NP	O
Expected	Expect	VBN	B-VP	O
post	post	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
mediastinal	mediastinal	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
Hospital	Hospital	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mult	mult	JJ	B-NP	O
small	small	JJ	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
Bridge	Bridge	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
qhs	qh	NNS	I-NP	O
.	.	.	O	O

HD	HD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
was	be	VBD	B-VP	O
2.8	2.8	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	O
of	of	IN	B-PP	O
02	02	CD	B-NP	O
with	with	IN	B-PP	O
02	02	CD	B-NP	O
sat	sit	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-DNA
02	02	CD	I-NP	I-DNA
.	.	.	O	O

Will	Will	MD	B-VP	O
decrease	decrease	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
to	to	TO	B-PP	O
8mg	8mg	NN	B-NP	O
qHS	qHS	NN	I-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-ADJP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
VNS	VNS	NN	B-NP	B-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Check	Check	VB	B-VP	O
INR	INR	NN	B-NP	B-protein
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WALLENBROCK	WALLENBROCK	NNP	B-NP	O
,	,	,	O	O
DAMON	DAMON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HI59	HI59	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/12/06	2/12/06	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

